Investing.com
Oppenheimer slashes NuCana stock target, remains Outperform on optimism for upcoming trials By Investing.com
On Tuesday, Oppenheimer adjusted its outlook on NuCana (NASDAQ:NCNA), reducing the price target to $25.00 from the previous $150.00 while maintaining an Outperform rating. The revision follows ...
9 hours ago